Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15834901 | 0.98 | TDP1 (0.33) | TDP1MGLL | |
| SCHEMBL17300572 | 0.90 | — | — | |
| SCHEMBL10297379 | 0.89 | MGLL (0.37) | MGLL | |
| SCHEMBL19302545 | 0.89 | ALDH1A1 (0.31) | — | |
| SCHEMBL14983812 | 0.85 | TDP1 (0.31) | TDP1 | |
| SCHEMBL15082423 | 0.84 | TDP1 (0.30) | TDP1 | |
| SCHEMBL5075511 | 0.82 | MGLL (0.42) | TDP1MGLL | |
| SCHEMBL16786513 | 0.80 | ALDH1A1 (0.38) | MGLL | |
| SCHEMBL11932954 | 0.80 | ALDH1A1 (0.32) | MGLL | |
| SCHEMBL9922280 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170247317-A1 | COMPOUNDS, MONOMERS, AND POLYMERS CONTAINING A CARBONATE LINKAGE | ISP INVESTMENTS LLC (US) | 2017-08-31 | — | — | US | disclosed |
| US-9650335-B2 | Compounds, monomers, and polymers containing a carbonate linkage | ISP INVESTMENTS LLC (US) | 2017-05-16 | — | — | US | disclosed |
| US-9334236-B2 | Lactam-based compounds with a urethane or urea functional group, and uses thereof | ISP INVESTMENTS INC. (US) | 2016-05-10 | — | — | US | disclosed |
| US-20150044161-A1 | MULTIFUNCTIONAL POLYMERS | ISP INVESTMENTS INC. (US) | 2015-02-12 | — | — | US | disclosed |
| US-20120149861-A1 | LACTAM-BASED COMPOUNDS WITH A URETHANE OR UREA FUNCTIONAL GROUP, AND USES THEREOF | ISP INVESTMENTS LLC | 2012-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150044161-A1 | MULTIFUNCTIONAL POLYMERS | PUF60, PARG, PARN | TDP1 2910/4885MGLL 479/4885 |
| US-20120149861-A1 | LACTAM-BASED COMPOUNDS WITH A URETHANE OR UREA FUNCTIONAL GROUP, AND USES THEREOF | CUTA, PUF60, PAM | TDP1 3431/4885MGLL 1116/4885 |
| US-20170247317-A1 | COMPOUNDS, MONOMERS, AND POLYMERS CONTAINING A CARBONATE LINKAGE | PARN, CD38, PARG | TDP1 3174/4885MGLL 3690/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.